Clinical Trial Update: Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiation therapy with docetaxel for HPV-related oropharyngeal cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-related Oropharyngeal Cancer
• Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Mayo Clinic | Conditions: Human Papillomavirus Infection, Stage I Oropharyngeal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2019-09-18